Hangzhou DAC Biotechnology Co., Ltd.
5 clinical trials · Sponsor
◉ Watch Hangzhou DAC Biotechnology Co., Ltd.
| Record | Firm | Date |
|---|---|---|
| DEC003M in Prostate Cancer (NCT07657806) | Hangzhou DAC Biotechnology Co., Ltd. | 2026-08-01 |
| A Study of DXC014 in Patients With Advanced Solid Tumors. (NCT07177937) | Hangzhou DAC Biotechnology Co., Ltd. | 2026-03-03 |
| A Study of DXC008 in Patients With Prostate Cancer and Other Solid Tumors (NCT06926283) | Hangzhou DAC Biotechnology Co., Ltd. | 2025-05-15 |
| A Study of DXC006 in Patients With Advanced Solid Tumors and Hematologic Malignancies (NCT06224855) | Hangzhou DAC Biotechnology Co., Ltd. | 2024-01-24 |
Track Hangzhou DAC Biotechnology Co., Ltd. automatically
Every clearance here is in the API, with alerts when new ones post.